Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F8AB
|
|||
| Drug Name |
PMID27376512-Compound-Figure3CM
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
PIERRE FABRE MEDICAMENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C36H37N7O2
|
|||
| Canonical SMILES |
C1CN(CCC1COC2=CC3=C(C=C2)C(=O)N(C=N3)CCNC4=CC=NC5=CC=CC=C54)CCNC6=CC=NC7=CC=CC=C76
|
|||
| InChI |
1S/C36H37N7O2/c44-36-30-10-9-27(23-35(30)41-25-43(36)22-18-40-34-12-16-38-32-8-4-2-6-29(32)34)45-24-26-13-19-42(20-14-26)21-17-39-33-11-15-37-31-7-3-1-5-28(31)33/h1-12,15-16,23,25-26H,13-14,17-22,24H2,(H,37,39)(H,38,40)
|
|||
| InChIKey |
ZJSGNMNKODEYPA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | DNA [cytosine-5]-methyltransferase 3A (DNMT3A) | Target Info | Inhibitor | [1] |
| Target's Patent Info | DNA [cytosine-5]-methyltransferase 3A (DNMT3A) | Target's Patent Info | [1] | |
| KEGG Pathway | Cysteine and methionine metabolism | |||
| Metabolic pathways | ||||
| MicroRNAs in cancer | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | DNA methyltransferase inhibitors: an updated patent review (2012-2015).Expert Opin Ther Pat. 2016 Sep;26(9):1017-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.